AHA: AstraZeneca, Moderna shine early light on mRNA potential in heart failure Kaiser Permanente strike of nearly 32,000 workers halted after last-second deal reached 2021's Fiercest Women in Life Sciences FDA flags safety issue in replacement material for recalled Philips ventilators AHA: Eli Lilly and Boehringer Ingelheim's Jardiance stays on its heart failure winning streak—this time in acute patients AHA: Bristol Myers, Janssen look to phase 3 as anticoagulant med aces proof-of-concept study AHA: Fitbit shows it can track down atrial fibrillation in 450,000-strong heart study AHA: J&J's Invokana chases AZ's Farxiga and Lilly's Jardiance with phase 3 heart failure win AHA: PhaseBio shows Brilinta reversal agent can work where it counts: in an emergency Amwell narrows 2021 revenue outlook due to delta variant impact on telehealth visit volume Medidata co-founder Glen de Vries dies in plane crash less than a month after Blue Origin flight CMS rescinds Trump-era rule expediting Medicare coverage of breakthrough devices Medtronic adds 2 new neuroscience execs plus strategy and digital innovation heads Thermo Fisher will build lab supply plant in North Carolina as part of $193M federal contract Featured Story | By Ben Adams Although AstraZeneca and Moderna are archrivals in the COVID-19 vaccine space, the two have an interesting mRNA pact that has been operating largely under the radar. read more |
| |
|---|
|
|
| Spinal Muscular Atrophy: Overview & Outlook SMA is a rare and devastating disease. This 2-part series provides an overview of SMA and current therapies. It also provides an outlook on potential advancements that could affect the therapeutic and commercial landscapes. Download now. |
Top Stories By Robert King Kaiser Permanente reached a tentative deal with the Alliance of Health Care Unions to avert a strike of nearly 32,000 workers set to go into effect Monday. read more By Annalee Armstrong “It took a village to make me.” These words spoken by WeiQing Zhou, who is the cofounder of two biotechs, could apply to almost any of the women on the 2021 Fiercest Women in Life Sciences list. read more By Andrea Park Months after Philips received the FDA’s go-ahead to begin repairing and replacing the ventilators affected by the Class I recall the company initiated in mid-June, the regulator identified a potential safety risk with a replacement component. read more By Kevin Dunleavy Three months after earning an approval to treat chronic heart failure with Jardiance, Eli Lilly and Boehringer Ingelheim have posted data that show the drug’s effectiveness against another type of heart failure. read more By Annalee Armstrong Bristol Myers took the rare step of tapping Johnson & Johnson’s Janssen unit to help develop new anticoagulant medicines back in 2018. Now, the Big Pharmas have the proof-of-concept data they need to prepare the partnership for late stage development. read more By Conor Hale A large-scale clinical trial of Fitbit’s pulse-tracking algorithm showed success in spotting the hidden signs of atrial fibrillation, demonstrating the capability of smartwatches and fitness trackers as a frontline screening device for the potentially dangerous heart condition. read more By Fraiser Kansteiner J&J's type 2 diabetes med Invokana helped improve patients' heart failure symptoms regardless of whether or not they had diabetes, phase 3 data presented at the American Heart Association's virtual Scientific Sessions 2021 showed. read more By Emmy Lucas PhaseBio had already shown its Brilinta reversal agent could work in healthy volunteers, but now the biotech has the phase 3 data to back up the therapy's use in patients who are in an emergency situation. read more By Heather Landi The rise of the highly infectious delta variant in the third quarter had an unexpected impact on telehealth company Amwell's virtual care visits as urgent care services grew but specialty and behavioral health services dropped. read more By Annalee Armstrong Glen de Vries, co-founder of the life sciences software provider Medidata, died in a plane crash last week, less than a month after flying to space with William Shatner aboard a Blue Origin rocket. read more By Dave Muoio The rule aimed to cut down the time between regulatory authorization and Medicare coverage determination for innovative technologies. It was finalized days before Biden took office. read more By Andrea Park With barely a month left in the year, Medtronic is shuffling up its executive team. read more By Joseph Keenan Thermo Fisher Scientific will build a manufacturing facility in North Carolina focused on making vital laboratory products as part of its $192.5 million contract with the U.S. Department of Health and Human Services. read more | 